Bryan Youree, MD
Basic profileBryan Youree is an Infectious Disease physician affiliated with Texas Health Harris Methodist Hospital Fort Worth. OpenAlex indexes 13 publications with 1,074 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20252 payments$38
- Gilead Sciences, Inc.Program year20251 payment$14
- ViiV Healthcare CompanyProgram year20246 payments$115
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
99.7%Lipoglycopeptide Antibacterial92.9%Dalbavancin100%Part B, office-administered≥24 patientsTetracycline-class Drug1.2%Doxycycline Hyclate86%Doxycycline Monohydrate8%Minocycline Hcl7%Part D<11 patients+ 14 more classes in this area
Sensory organs
0.2%Fluoroquinolone Antibacterial0.1%Ciprofloxacin Hcl100%Part D<11 patientsCorticosteroid0.1%Dexamethasone Sodium Phosphate100%Part D<11 patientsRespiratory
0.1%Histamine-1 Receptor Antagonist0.1%Diphenhydramine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P-228. A Multidisciplinary Approach to Reducing Central Line-Associated Bloodstream Infections (CLABSI)
Open Forum Infectious Diseases
2025 - Successful management of mycotic visceral aneurysms in a LVAD patient and navigating LVAD postoperative challenges
Journal of Vascular Surgery Cases and Innovative Techniques
2024 - Successful Management of Mycotic Visceral Aneurysms in a LVAD Patient: Navigating Postoperative Challenges
The Journal of Heart and Lung Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Moritz Wyler Von Ballmoos, MD/PHD/MPH
Texas Health Harris Methodist Hospital Fort Worth
Cory Collinge, MD
Texas Health Harris Methodist Hospital Fort Worth
William Witham, MD
Texas Health Harris Methodist Hospital Fort Worth
Hugo Sanchez, MD
Texas Health Harris Methodist Hospital Fort Worth
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”